The Immunohaematology business is a stand-alone business unit operating under CSL Bioplasma.
Our core skills include the manufacture of Reagent Red Blood Cells (RRBCs), monoclonal antibodies and the production of reagents and ancillary products for immunohaematology laboratories.
CSL Bioplasma Immunohaematology works closely with the Australian Commonwealth Government Department of Health and Ageing, National Blood Authority and the Australian Red Cross Blood Service to supply vital RRBCs to Australian transfusion and pathology laboratories. CSL Bioplasma Immunohaematology is proud of our involvement in the excellent safety record of blood transfusion in Australia, through the development, manufacture and unfailing provision of Reagent Red Blood Cell (RRBC) products over the past 20 years.